Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
MGdufNTxPJ2F2nEn
Listen
